Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients

1 Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial The Lancet Oncology, April 24, 2013

2 Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis Nutrition Reviews, April 30, 2013    Evidence Based Medicine    Review Article

3 Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on Nidogen-1 and Nidogen-2 International Journal of Cancer, May 20, 2013

4 A risk for hepatocellular carcinoma still persists long-term after sustained virological response in patients with hepatitis C associated liver cirrhosis Clinical Infectious Diseases, April 26, 2013

5 Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study The Lancet Oncology, April 24, 2013

6 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

7 Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barretts and oesophageal carcinoma: association or causality Alimentary Pharmacology and Therapeutics, April 29, 2013

8 Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma Annals of Oncology, May 14, 2013

9 Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma Diseases of the Esophagus, April 30, 2013

10 Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States Journal of Clinical Oncology, May 9, 2013